Evidence map›Paper›PMID 36690433›Full record

ArticleGut2023

Large-scale, national, family-based epidemiological study on

Xian-Zhu Zhou, Nong-Hua Lyu, Hui-Yun Zhu, Quan-Cai Cai, Xiang-Yu Kong, Pei Xie, Li-Ya Zhou, Song-Ze Ding, Zhao-Shen Li, Yi-Qi Du and 1 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Gut, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 92 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 8 pooled it
45.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05997433 naunknown statusnot on this map

Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori : A Multicenter Randomized Non-Inferiority Trial

TypeinterventionalSponsorShandong UniversityRan2023 to 2024Enrolled254ConditionsHelicobacter Pylori InfectionArms7days bismuth quadruple, 14 days bismuth quadruple
NCT06412640 phase4unknown statusnot on this mapstarted 2024, after this paper: background citation

Eradication of Helicobacter Pylori by 14-day Dual Therapy of Keverprazan in Combination With Low-dose and High-dose Amoxicillin: a Prospective, Single-center, Developmental-label, Randomized Controlled Study

TypeinterventionalSponsorNanjing First Hospital, Nanjing Medical UniversityRan2024 to 2025Enrolled268ConditionsH. Pylori InfectionArmsKeverprazan, Amoxicillin
3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 8 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Gastric cancer prevention byFrontiers in oncology · 2026
    Pooled it
  2. Research trends of nanomaterials inFrontiers in pharmacology · 2025
    Pooled it
  3. Social determinants of health andFrontiers in public health · 2025
    Pooled it
  4. Bibliometric analysis ofFrontiers in microbiology · 2025
    Pooled it
  5. Prevalence ofWorld journal of gastroenterology · 2024
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Bidirectional relationship betweenFrontiers in nutrition · 2024
    Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Trends inThe Lancet regional health. Western Pacific · 2026
    Article
  16. Article
  17. Prevalence ofJGH open : an open access journal of gastroenterology and hepatology · 2026
    Article
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Xian-Zhu Zhou *Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.ORCID 0000-0002-8861-8563
Nong-Hua Lyu *Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.ORCID 0000-0003-4373-551X
Hui-Yun Zhu *Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.ORCID 0000-0003-4580-8700
Quan-Cai CaiDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.ORCID 0000-0002-0163-1942
Xiang-Yu KongDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.ORCID 0000-0001-7515-2613
Pei XieDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Li-Ya ZhouDepartment of Gastroenterology, Peking University Third Hospital, Beijing, China.ORCID 0000-0002-8636-9989
Song-Ze DingDepartment of Gastroenterology and Hepatology, People's Hospital of Zhengzhou University, and People's Hospital of Henan University, Zhengzhou, Henan, China duyiqi@hotmail.com zhsl@vip.163.com dingsongze@hotmail.com.ORCID 0000-0002-4589-6942
Zhao-Shen LiDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China duyiqi@hotmail.com zhsl@vip.163.com dingsongze@hotmail.com.ORCID 0000-0002-1963-2070
Yi-Qi DuDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China duyiqi@hotmail.com zhsl@vip.163.com dingsongze@hotmail.com.ORCID 0000-0002-4261-6888
National Clinical Research Center for Digestive Diseases (Shanghai), Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA), Helicobacter pylori Study Group of Chinese Society of Gastroenterology and Chinese Alliance for Helicobacter pylori Study.
Second Military Medical University · CNHenan University · CNNanchang University · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsCurrent practice on

methodsFrom September 2021 to December 2021, 10 735 families (31 098 individuals) were enrolled from 29 of 31 provinces in mainland China to examine family-based

resultsAmong all participants, the average individual-based

conclusionFamilial

Indexed as

Helicobacter InfectionsHelicobacter pyloriAdolescentAdultChildChinaEpidemiologic StudiesFamilyHumansPrevalenceRisk FactorsGASTRIC CANCERGASTRIC PRE-CANCERHELICOBACTER PYLORI - EPIDEMIOLOGYHELICOBACTER PYLORI - GASTRITISHELICOBACTER PYLORI INFECTION

Identifiers

PMID36690433
PMCPMC10086479
OpenAlexW4317762112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.